A Randomized, Pilot Study of Ruxolitinib in Antiretroviral-Treated HIV-Infected Adults
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs Ruxolitinib (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 23 Apr 2018 Status changed from active, no longer recruiting to completed.
- 06 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 8 Mar 2018.